This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (346)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Bioterrorism  • Alert me on articles by topic

Medical and Public Health Management

Thomas V. Inglesby, MD; Donald A. Henderson, MD, MPH; John G. Bartlett, MD; Michael S. Ascher, MD; Edward Eitzen, MD, MPH; Arthur M. Friedlander, MD; Jerome Hauer, MPH; Joseph McDade, PhD; Michael T. Osterholm, PhD, MPH; Tara O'Toole, MD, MPH; Gerald Parker, PhD, DVM; Trish M. Perl, MD, MSc; Philip K. Russell, MD; Kevin Tonat, PhD; for the Working Group on Civilian Biodefense

JAMA. 1999;281:1735-1745.

Objective  To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population.

Participants  The working group included 21 representatives from staff of major academic medical centers and research, government, military, public health, and emergency management institutions and agencies.

Evidence  MEDLINE databases were searched from January 1966 to April 1998, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of references identified by this search led to identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources.

Consensus Process  The first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. Members of the working group provided formal written comments which were incorporated into the second draft of the statement. The working group reviewed the second draft on June 12, 1998. No significant disagreements existed and comments were incorporated into a third draft. The fourth and final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members.

Conclusions  Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs.

Author Affiliations: The Center for Civilian Biodefense Studies (Drs Inglesby, Henderson, Bartlett, O'Toole, Perl, and Russell), and the Schools of Medicine (Drs Inglesby, Bartlett, and Perl) and Public Health (Drs Henderson, O'Toole, and Russell), Johns Hopkins University, Baltimore, Md; Viral and Rickettsial Diseases, California Department of Health, Berkeley (Dr Ascher); US Army Medical Research Institute of Infectious Diseases, Frederick, Md (Drs Eitzen, Friedlander, and Parker); Office of Emergency Management, New York, NY (Mr Hauer); Centers for Disease Control and Prevention, Atlanta, Ga (Dr McDade); Acute Disease Epidemiology, Minnesota Department of Health, Minneapolis (Dr Osterholm); and the Office of Emergency Preparedness, Department of Health and Human Services, Rockville, Md (Dr Tonat).

RELATED ARTICLES

Biological Warfare in the 1940s and 1950s
Stephen Endicott, Edward Hagerman, Martin Furmanski, and Henry Wilde
JAMA. 2000;284(5):561.
EXTRACT | FULL TEXT  

May 12, 1999
JAMA. 1999;281(18):1765-1766.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase
Carnrot et al.
Protein Sci. 2008;17:1486-1493.
ABSTRACT | FULL TEXT  

Gamma Irradiation Can Be Used To Inactivate Bacillus anthracis Spores without Compromising the Sensitivity of Diagnostic Assays
Dauphin et al.
Appl. Environ. Microbiol. 2008;74:4427-4433.
ABSTRACT | FULL TEXT  

Modeling the Incubation Period of Inhalational Anthrax
Wilkening
Med Decis Making 2008;28:593-605.
ABSTRACT  

Behavior of Bacillus anthracis Strains Sterne and Ames K0610 in Sterile Raw Ground Beef
Tamplin et al.
Appl. Environ. Microbiol. 2008;74:1111-1116.
ABSTRACT | FULL TEXT  

In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant Bacillus anthracis
Barrow et al.
Antimicrob. Agents Chemother. 2007;51:4447-4452.
ABSTRACT | FULL TEXT  

Disasters and Mass Casualties: II. Explosive, Biologic, Chemical, and Nuclear Agents
Born et al.
J Am Acad Orthop Surg 2007;15:461-473.
ABSTRACT | FULL TEXT  

Reaerosolization of Fluidized Spores in Ventilation Systems
Krauter and Biermann
Appl. Environ. Microbiol. 2007;73:2165-2172.
ABSTRACT | FULL TEXT  

Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats: Basic, Clinical, and Population Science Research and Training Needs
Madjid et al.
J Am Coll Cardiol 2007;49:1407-1412.
FULL TEXT  

Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence.
Thwaite et al.
Antimicrob. Agents Chemother. 2006;50:2316-2322.
ABSTRACT | FULL TEXT  

Sverdlovsk revisited: Modeling human inhalation anthrax
Wilkening
Proc. Natl. Acad. Sci. USA 2006;103:7589-7594.
ABSTRACT | FULL TEXT  

The cost-effectiveness of strategies to reduce mortality from an intentional release of aerosolized anthrax spores.
Braithwaite et al.
Med Decis Making 2006;26:182-193.
ABSTRACT  

Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice
Brook et al.
J Antimicrob Chemother 2005;56:1074-1080.
ABSTRACT | FULL TEXT  

Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without 60Co gamma-photon irradiation
Brook et al.
J Med Microbiol 2005;54:1157-1162.
ABSTRACT | FULL TEXT  

Comparison of Minisatellite Polymorphisms in the Bacillus cereus Complex: a Simple Assay for Large-Scale Screening and Identification of Strains Most Closely Related to Bacillus anthracis
Valjevac et al.
Appl. Environ. Microbiol. 2005;71:6613-6623.
ABSTRACT | FULL TEXT  

Inter-Alpha-Inhibitor Proteins Are Endogenous Furin Inhibitors and Provide Protection against Experimental Anthrax Intoxication
Opal et al.
Infect. Immun. 2005;73:5101-5105.
ABSTRACT | FULL TEXT  

Understanding health literacy: an expanded model
Zarcadoolas et al.
HEALTH PROMOT INT 2005;20:195-203.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax
Fowler et al.
ANN INTERN MED 2005;142:601-610.
ABSTRACT | FULL TEXT  

A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge
Mohamed et al.
Infect. Immun. 2005;73:795-802.
ABSTRACT | FULL TEXT  

Murine Macrophage Transcriptional Responses to Bacillus anthracis Infection and Intoxication
Bergman et al.
Infect. Immun. 2005;73:1069-1080.
ABSTRACT | FULL TEXT  

Rabbit and Nonhuman Primate Models of Toxin-Targeting Human Anthrax Vaccines
Phipps et al.
Microbiol. Mol. Biol. Rev. 2004;68:617-629.
ABSTRACT | FULL TEXT  

Functional Cloning of Bacillus anthracis Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim
Barrow et al.
Antimicrob. Agents Chemother. 2004;48:4643-4649.
ABSTRACT | FULL TEXT  

Real-Time PCR Assay for a Unique Chromosomal Sequence of Bacillus anthracis
Bode et al.
J. Clin. Microbiol. 2004;42:5825-5831.
ABSTRACT | FULL TEXT  

Sex-Related Differences in the Pharmacokinetics of Oral Ciprofloxacin
Overholser et al.
J Clin Pharmacol 2004;44:1012-1022.
ABSTRACT | FULL TEXT  

Activities of Different Fluoroquinolones against Bacillus anthracis Mutants Selected In Vitro and Harboring Topoisomerase Mutations
Grohs et al.
Antimicrob. Agents Chemother. 2004;48:3024-3027.
ABSTRACT | FULL TEXT  

Pharmacy Preparedness for Incidents Involving Nuclear, Biological, or Chemical Weapons
Burda and Sigg
Journal of Pharmacy Practice 2004;17:251-265.
ABSTRACT  

One-Year Health Assessment of Adult Survivors of Bacillus anthracis Infection
Reissman et al.
JAMA 2004;291:1994-1998.
ABSTRACT | FULL TEXT  

Differentiating Inhalational Anthrax From Other Influenzalike Illnesses in the Setting of a National or Regional Anthrax Outbreak
Cinti et al.
Arch Intern Med 2004;164:674-676.
ABSTRACT | FULL TEXT  

A Conceptual Framework for Evaluating Information Technologies and Decision Support Systems for Bioterrorism Preparedness and Response
Bravata et al.
Med Decis Making 2004;24:192-206.
ABSTRACT  

Species-Specific Peptide Ligands for the Detection of Bacillus anthracis Spores
Williams et al.
Appl. Environ. Microbiol. 2003;69:6288-6293.
ABSTRACT | FULL TEXT  

Inhalational Anthrax: Radiologic and Pathologic Findings in Two Cases
Wood et al.
Am. J. Roentgenol. 2003;181:1071-1078.
FULL TEXT  

Accuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack
Hupert et al.
ANN INTERN MED 2003;139:337-345.
ABSTRACT | FULL TEXT  

Creating a Text Classifier to Detect Radiology Reports Describing Mediastinal Findings Associated with Inhalational Anthrax and Other Disorders
Chapman et al.
J. Am. Med. Inform. Assoc. 2003;10:494-503.
ABSTRACT | FULL TEXT  

Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak
Brookmeyer et al.
Proc. Natl. Acad. Sci. USA 2003;100:10129-10132.
ABSTRACT | FULL TEXT  

Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide
Frean et al.
J Antimicrob Chemother 2003;52:297-299.
ABSTRACT | FULL TEXT  

Is SARS Just ARDS?
Rubenfeld
JAMA 2003;290:397-399.
FULL TEXT  

Commentary on "New Challenges for Public Health Care: Biological and Chemical Weapons Awareness, Surveillance, and Response"
Schoch-Spana
Biol Res Nurs 2003;4:251-254.
 

Novel Sample Preparation Method for Safe and Rapid Detection of Bacillus anthracis Spores in Environmental Powders and Nasal Swabs
Luna et al.
J. Clin. Microbiol. 2003;41:1252-1255.
ABSTRACT | FULL TEXT  

Bacillus anthracis
Spencer
J. Clin. Pathol. 2003;56:182-187.
ABSTRACT | FULL TEXT  

Radiologic Manifestations of Potential Bioterrorist Agents of Infection
Ketai et al.
Am. J. Roentgenol. 2003;180:565-575.
FULL TEXT  

PCR Assay To Detect Bacillus anthracis Spores in Heat-Treated Specimens
Fasanella et al.
J. Clin. Microbiol. 2003;41:896-899.
ABSTRACT | FULL TEXT  

Figs -- The Earliest Known Ancient Drug for Cutaneous Anthrax
Ben-Noun
The Annals of Pharmacotherapy 2003;37:297-300.
ABSTRACT | FULL TEXT  

Neurological Aspects of Biological and Chemical Terrorism: A Review for Neurologists
Martin and Adams
Arch Neurol 2003;60:21-25.
ABSTRACT | FULL TEXT  

Secondary Aerosolization of Viable Bacillus anthracis Spores in a Contaminated US Senate Office
Weis et al.
JAMA 2002;288:2853-2858.
ABSTRACT | FULL TEXT  

Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates
Drago et al.
J Antimicrob Chemother 2002;50:1059-1063.
ABSTRACT | FULL TEXT  

More Bioterrorism
Madariaga et al.
Pediatrics 2002;110:1257-1258.
FULL TEXT  

Antimicrobial Therapy for Bacillus anthracis-Induced Polymicrobial Infection in 60Co {gamma}-Irradiated Mice
Elliott et al.
Antimicrob. Agents Chemother. 2002;46:3463-3471.
ABSTRACT | FULL TEXT  

Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs
Altboum et al.
Infect. Immun. 2002;70:6231-6241.
ABSTRACT | FULL TEXT  

Anthrax as a Biological Weapon: An Old Disease That Poses a New Threat
Tasota et al.
Crit Care Nurse 2002;22:21-34.
FULL TEXT  

Anthrax meningoencephalitis
Lanska
Neurology 2002;59:327-334.
ABSTRACT | FULL TEXT  

The Model State Emergency Health Powers Act: Planning for and Response to Bioterrorism and Naturally Occurring Infectious Diseases
Gostin et al.
JAMA 2002;288:622-628.
ABSTRACT | FULL TEXT  

Detection of Bacillus anthracis DNA by LightCycler PCR
Bell et al.
J. Clin. Microbiol. 2002;40:2897-2902.
ABSTRACT | FULL TEXT  

Large-Scale Screening of Nasal Swabs for Bacillus anthracis: Descriptive Summary and Discussion of the National Institutes of Health's Experience
Kiratisin et al.
J. Clin. Microbiol. 2002;40:3012-3016.
ABSTRACT | FULL TEXT  

Management of Patients Exposed to Biological and Chemical Warfare Agents
Marik and Bowles
J Intensive Care Med 2002;17:147-161.
ABSTRACT  

Antimicrobial Susceptibility Testing of Bacillus anthracis: Comparison of Results Obtained by Using the National Committee for Clinical Laboratory Standards Broth Microdilution Reference and Etest Agar Gradient Diffusion Methods
Mohammed et al.
J. Clin. Microbiol. 2002;40:1902-1907.
ABSTRACT | FULL TEXT  

Mailborne transmission of anthrax: Modeling and implications
Webb and Blaser
Proc. Natl. Acad. Sci. USA 2002;99:7027-7032.
ABSTRACT | FULL TEXT  

Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Borio et al.
JAMA 2002;287:2391-2405.
ABSTRACT | FULL TEXT  

Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management
Inglesby et al.
JAMA 2002;287:2236-2252.
ABSTRACT | FULL TEXT  

Dynamic CT Features of Inhalational Anthrax Infection
Krol et al.
Am. J. Roentgenol. 2002;178:1063-1066.
FULL TEXT  

Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales
Goldenberg et al.
Proc. Natl. Acad. Sci. USA 2002;99:5237-5240.
ABSTRACT | FULL TEXT  

Responding to Chemical, Biological, or Nuclear Terrorism: The Indirect and Long-Term Health Effects May Present the Greatest Challenge
Hyams et al.
Journal of Health Politics, Policy and Law 2002;27:273-292.
ABSTRACT  

Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women
Wiesen and Littell
JAMA 2002;287:1556-1560.
ABSTRACT | FULL TEXT  

Recognition and Management of Anthrax
McGovern et al.
NEJM 2002;346:943-945.
FULL TEXT  

Prevention of Inhalational Anthrax in the U.S. Outbreak
Brookmeyer and Blades
Science 2002;295:1861-1861.
FULL TEXT  

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Mina et al.
JAMA 2002;287:858-862.
ABSTRACT | FULL TEXT  

Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant
Freedman et al.
JAMA 2002;287:869-874.
ABSTRACT | FULL TEXT  

Biological warfare and bioterrorism
Beeching et al.
BMJ 2002;324:336-339.
FULL TEXT  

Quinolones and False-Positive Urine Screening for Opiates by Immunoassay Technology
Baden et al.
JAMA 2001;286:3115-3119.
ABSTRACT | FULL TEXT  

Large-Scale Quarantine Following Biological Terrorism in the United States: Scientific Examination, Logistic and Legal Limits, and Possible Consequences
Barbera et al.
JAMA 2001;286:2711-2717.
ABSTRACT | FULL TEXT  

Clinical Presentation of Inhalational Anthrax Following Bioterrorism Exposure: Report of 2 Surviving Patients
Mayer et al.
JAMA 2001;286:2549-2553.
ABSTRACT | FULL TEXT  

Death Due to Bioterrorism-Related Inhalational Anthrax: Report of 2 Patients
Borio et al.
JAMA 2001;286:2554-2559.
ABSTRACT | FULL TEXT  

Bioterrorism on the Home Front: A New Challenge for American Medicine
Lane and Fauci
JAMA 2001;286:2595-2597.
FULL TEXT  

Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons With Possible Anthrax
JAMA 2001;286:2392-2396.
FULL TEXT  

Anthrax
Journal Watch Dermatology 2001;2001:6-6.
FULL TEXT  

Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
JAMA 2001;286:2226-2232.
FULL TEXT  

Recognition of Illness Associated With the Intentional Release of a Biologic Agent
JAMA 2001;286:2088-2090.
FULL TEXT  

Prophylactic treatment of anthrax with antibiotics
Hart and Beeching
BMJ 2001;323:1017-1018.
FULL TEXT  

Tularemia as a Biological Weapon: Medical and Public Health Management
Dennis et al.
JAMA 2001;285:2763-2773.
ABSTRACT | FULL TEXT  

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon et al.
JAMA 2001;285:1059-1070.
ABSTRACT | FULL TEXT  

Anthrax: of bison and bioterrorism
Weir
CMAJ 2000;163:608-608.
FULL TEXT  

Biological Warfare in the 1940s and 1950s
Endicott et al.
JAMA 2000;284:561-561.
FULL TEXT  

Surveillance for Adverse Events Associated With Anthrax Vaccination--US Department of Defense, 1998-2000
JAMA 2000;283:2648-2649.
FULL TEXT  

Plague as a Biological Weapon: Medical and Public Health Management
Inglesby et al.
JAMA 2000;283:2281-2290.
ABSTRACT | FULL TEXT  

Pharmacy Preparedness for Incidents Involving Weapons of Mass Destruction
Burda and Sigg
Journal of Pharmacy Practice 2000;13:141-155.
ABSTRACT  

Chemical-Biological Terrorism and Its Impact on Children: A Subject Review
Committee on Environmental Health and Committee on
Pediatrics 2000;105:662-670.
ABSTRACT | FULL TEXT  

Weapons of Mass Destruction Events With Contaminated Casualties: Effective Planning for Health Care Facilities
Macintyre et al.
JAMA 2000;283:242-249.
ABSTRACT | FULL TEXT  

Domestic Preparedness for Events Involving Weapons of Mass Destruction
Waeckerle
JAMA 2000;283:252-254.
FULL TEXT  

Anthrax Vaccine: Evidence for Safety and Efficacy Against Inhalational Anthrax
Friedlander et al.
JAMA 1999;282:2104-2106.
FULL TEXT  

Recognition and Treatment of Anthrax
Nalin et al.
JAMA 1999;282:1624-1625.
FULL TEXT  

Inhalational Anthrax: Epidemiology, Diagnosis, and Management
Shafazand et al.
Chest 1999;116:1369-1376.
ABSTRACT | FULL TEXT  

Anthrax
Dixon et al.
NEJM 1999;341:815-826.
FULL TEXT  

Smallpox as a Biological Weapon: Medical and Public Health Management
Henderson et al.
JAMA 1999;281:2127-2137.
ABSTRACT | FULL TEXT  

Index Case of Fatal Inhalational Anthrax Due to Bioterrorism in the United States
Bush et al.
NEJM 2001;345:1607-1610.
FULL TEXT  

Recognition and Management of Anthrax -- An Update
Swartz
NEJM 2001;345:1621-1626.
FULL TEXT  

Inhalational Anthrax after Bioterrorism Exposure: Spectrum of Imaging Findings in Two Surviving Patients
Earls et al.
Radiology 2002;222:305-312.
ABSTRACT | FULL TEXT